Gene · 9113
Papers3,081
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,581 to 1,600 of 3,081
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mechano-therapeutics: Targeting Mechanical Signaling in Fibrosis and Tumor Stroma. | Pharmacol Ther | 2020 | 32437826 | PubTator, text mining | PubMed |
| Uncovering the prognostic gene signatures for the improvement of risk stratification in cancers by using deep learning algorithm coupled with wavelet transform. | BMC Bioinformatics | 2020 | 32429941 | PubTator, text mining | PubMed |
| Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells. | Front Oncol | 2020 | 32426267 | PubTator, text mining | PubMed |
| Association analysis between SNPs in LATS1 and LATS2 and non-cardia gastric cancer. | BMC Gastroenterol | 2020 | 32423384 | PubTator, text mining | PubMed |
| Expression of large tumour suppressor (LATS) kinases modulates chemotherapy response in advanced non-small cell lung cancer. | Transl Lung Cancer Res | 2020 | 32420069 | PubTator, text mining | PubMed |
| Emerging Mechanisms and Disease Relevance of Ferroptosis. | Trends Cell Biol | 2020 | 32413317 | PubTator, text mining | PubMed |
| Circular RNA KIF4A promotes cell migration, invasion and inhibits apoptosis through miR-152/ZEB1 axis in breast cancer. | Diagn Pathol | 2020 | 32408908 | PubTator, text mining | PubMed |
| YAP1/TAZ drives ependymoma-like tumour formation in mice. | Nat Commun | 2020 | 32404936 | PubTator, text mining | PubMed |
| Long noncoding RNA MACC1-AS1 promotes the stemness of nonsmall cell lung cancer cells through promoting UPF1-mediated destabilization of LATS1/2. | Environ Toxicol | 2020 | 32401390 | PubTator, text mining | PubMed |
| Novel tumor mutation score versus tumor mutation burden in predicting survival after immunotherapy in pan-cancer patients from the MSK-IMPACT cohort. | Ann Transl Med | 2020 | 32395490 | PubTator, text mining | PubMed |
| Comprehensive germline genomic profiles of children, adolescents and young adults with solid tumors. | Nat Commun | 2020 | 32371905 | PubTator, text mining | PubMed |
| The Hippo Pathway Transducers YAP1/TEAD Induce Acquired Resistance to Trastuzumab in HER2-Positive Breast Cancer. | Cancers (Basel) | 2020 | 32365528 | PubTator, text mining | PubMed |
| Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment. | Ann Transl Med | 2020 | 32355843 | PubTator, text mining | PubMed |
| LncRNA DRAIC inhibits proliferation and metastasis of gastric cancer cells through interfering with NFRKB deubiquitination mediated by UCHL5. | Cell Mol Biol Lett | 2020 | 32351584 | PubTator, text mining | PubMed |
| Update in the Management of Basal Cell Carcinoma. | Acta Derm Venereol | 2020 | 32346750 | PubTator, text mining | PubMed |
| The YAP/TAZ Pathway in Osteogenesis and Bone Sarcoma Pathogenesis. | Cells | 2020 | 32326412 | PubTator, text mining | PubMed |
| Waking up quiescent neural stem cells: Molecular mechanisms and implications in neurodevelopmental disorders. | PLoS Genet | 2020 | 32324743 | PubTator, text mining | PubMed |
| Programmable Synthetic Protein Circuits for the Identification and Suppression of Hepatocellular Carcinoma. | Mol Ther Oncolytics | 2020 | 32322664 | PubTator, text mining | PubMed |
| YAP Attenuates CD8 T Cell-Mediated Anti-tumor Response. | Front Immunol | 2020 | 32322254 | PubTator, text mining | PubMed |
| ANKHD1 promotes proliferation and invasion of non‑small‑cell lung cancer cells via regulating YAP oncoprotein expression and inactivating the Hippo pathway. | Int J Oncol | 2020 | 32319569 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9113/papers?page=80